Effect of 5 Days Linaclotide on Transit and Bowel Function in Females With Constipation-Predominant Irritable Bowel Syndrome
- 1 September 2007
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 133 (3), 761-768
- https://doi.org/10.1053/j.gastro.2007.06.067
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Functional Bowel DisordersGastroenterology, 2006
- Irritable Bowel SyndromeDrugs, 2006
- Effects of Single Dose Administration of MD-1100 on Safety, Tolerability, Exposure, and Stool Consistency in Healthy SubjectsAmerican Journal of Gastroenterology, 2005
- Mechanisms in IBS: something old, something new, something borrowed…Neurogastroenterology & Motility, 2005
- ANTINOCICEPTIVE ACTIONS OF MD-1100, A NOVEL THERAPEUTIC AGENT FOR c-IBS, IN ANIMAL MODELS OF VISCERAL PAINAmerican Journal of Gastroenterology, 2004
- AGA technical review on irritable bowel syndromeGastroenterology, 2002
- Functional bowel disorders and functional abdominal painGut, 1999
- Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiologyRegulatory Peptides, 1999
- Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase.Proceedings of the National Academy of Sciences, 1993
- Guanylin: an endogenous activator of intestinal guanylate cyclase.Proceedings of the National Academy of Sciences, 1992